Navigation Links
The Endotrac™ System For Endoscopic Carpal Tunnel Releases (ECTR)

ProductsThe Endotrac™ System For Endoscopic Carpal Tunnel Releases (ECTR)
Company Instratek Incorporated
Item The Endotrac™ System For Endoscopic Carpal Tunnel Releases (ECTR)
Features 
  • Includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray
  • Designed to be used with a standard 4.0 mm, 30 degree scope
    • Description The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade.
    Info Instratek Incorporated
    Customer Service: (800) 892-8020
    Web site: http://www.instratek.com

    Related medicine products :

    1. Silicone Oil Cannula System - 20 Gauge
    2. Silicone Oil Cannula System - 19 Gauge
    3. SuperVu Galilean System
    4. KOWA nonmyd 7 / VK-2 Digital Imaging System
    5. KOWA nonmyd a-D / VK-2 Digital Imaging System
    6. Refraction System RT-2100
    7. Odyssey Phacoemulsification System
    8. SIStem Phacoemulsification System
    9. Precisionist Phacoemulsification System
    10. Photon Laser Phacoemulsification System
    11. Phaco-Emulsification System
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    ...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
    Medicine Products:
    (Date:12/3/2008)...RDAM, The Netherlands, and LOS ANGELES, Dec. 3 /PR...Kari Boiler as the President of Bugaboo,Americas.... North America for,the past 5 years. "Kari Boiler... leader but a great team player with the vision th...ays Arjan Muis, CEO of Bugaboo International. , ...
    (Date:12/3/2008)...RANCISCO, Dec. 3 The Am...nnual High School Student Symposium at the San Fra...inning at 8:00 a.m. PST. The symposium, which enco...ciences, and medical research, is held in conjunct...ear, students will have the opportunity to explore...
    (Date:12/3/2008)...RANCISCO, Dec. 3 The Am...rgest professional society of blood specialists, w...resentatives and the Deputy Director of the Nation...eir efforts to promote biomedical research. The Pu...on with the Society,s 50th Annual Meeting in San F...
    (Date:12/3/2008)... LAUREL, N.J., Dec. 3 MedQuist Inc...tion Service Organization (MTSO) in the world, is ...eral material legal matters , , Resolution...y announced, the Company received an administrativ...tes Department of Justice ("DOJ") on December 17, ...
    Breaking Medicine News(10 mins):Health News:Kari Boiler Named President of Bugaboo Americas 2Health News:ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2Health News:ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research 2Health News:ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6
    ...anced/metastatic breast cancer in postmenopausal w...sts as a second line of treatment for infertility ...ozole was used not on an experimental basis, but a...ovulation. However some feel that without clinica...
    ...by may perhaps will like to have pomegranate juice...n prevent brain injury the fetus may be at risk fr...pre-term delivery. Pomegranate juice contains poly...have been linked with potential property of neurop...
    ...y been under a lot of cloud because of its alleged...study from the Women's Health Initiative (WHI) sho...suitable for perimenopausal and postmenopausal wom...is the treatnment procedure that uses medication c...
    ...led trial was done by Felicity cutts and colleague...eumococcal Conjugate Vaccine (9-PCV) against radio...occal disesase in children immunized before 12 mon...educe the incidence of vaccine type invasive pneum...
    Other Medicine News:Health News:Justifying the use of letrozole for inducing ovulation 2
    (Date:12/3/2008)...ll/ -- Sangamo BioSciences, Inc.,(Nasdaq: SGMO ...e on milestones,achieved in 2008 and preview obje...alyst Briefing to be held in New York City today. ...ich Corporation,s Research,Biotech Business Unit ...f the,two companies, collaboration to commerciali...
    (Date:12/3/2008)...-FirstCall/ -- Isis Pharmaceuticals,Inc. (Nasdaq...uticals, Inc.,provided positive survival results ...11 in combination with docetaxel and prednisone ("...isone alone ("the control arm") for first-line,tr...cancer. The current 10.6,month median overall su...
    (Date:12/2/2008)...-FirstCall/ -- Biopure Corporation,(Nasdaq: BPU...search Center,(NMRC) has submitted to the Food an...onal new drug (IND) application to conduct a clini...opure(R) [hemoglobin glutamer - 250 (bovine)],for...patients. The study is,entitled "Operation Restor...
    (Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
    Breaking Medicine Technology:Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 2Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 3Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 4Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 5Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives 6Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 2Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 3Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study 4U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Advanced Cell Technologys Dr Robert Lanza Makes List of 100 Most Inspiring People in the Life Sciences Industry 120 1Advanced Cell Technologys Dr Robert Lanza Makes List of 100 Most Inspiring People in the Life Sciences Industry 120 2Advanced Cell Technologys Dr Robert Lanza Makes List of 100 Most Inspiring People in the Life Sciences Industry 120 3YM BIOSCIENCES EUROPEAN PARTNER ONCOSCIENCE AG ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 119 1YM BIOSCIENCES EUROPEAN PARTNER ONCOSCIENCE AG ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 119 2YM BIOSCIENCES EUROPEAN PARTNER ONCOSCIENCE AG ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 119 3YM BIOSCIENCES EUROPEAN PARTNER ONCOSCIENCE AG ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER 119 4AMDL Announces 2nd Quarter 2007 Operational Results 116 1AMDL Announces 2nd Quarter 2007 Operational Results 116 2Genta Initiates Phase 3 AGENDA Trial of Genasense 28R 29 for Patients with Advanced Melanoma 109 1Genta Initiates Phase 3 AGENDA Trial of Genasense 28R 29 for Patients with Advanced Melanoma 109 2Genta Initiates Phase 3 AGENDA Trial of Genasense 28R 29 for Patients with Advanced Melanoma 109 3Genta Initiates Phase 3 AGENDA Trial of Genasense 28R 29 for Patients with Advanced Melanoma 109 4Genta Initiates Phase 3 AGENDA Trial of Genasense 28R 29 for Patients with Advanced Melanoma 109 5